Filters: author is van Laar [Clear All Filters]
- 2005
Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment,
J Control Release, vol. 101, no. 1-3, pp. 199-208. DOI
- 1999
Future delivery systems for apomorphine in patients with Parkinson's disease,
Adv Neurol, vol. 80, pp. 535-44.
- 1998
An integrated pharmacokinetic-pharmacodynamic approach to optimization of R-apomorphine delivery in Parkinson's disease,
Adv Drug Deliv Rev, vol. 33, no. 3, pp. 253-263. DOI
Pharmacokinetics, enantiomer interconversion, and metabolism of R-apomorphine in patients with idiopathic Parkinson's disease,
Clin Neuropharmacol, vol. 21, no. 3, pp. 159-68.
Stepwise intravenous infusion of apomorphine to determine the therapeutic window in patients with Parkinson's disease,
Clin Neuropharmacol, vol. 21, no. 3, pp. 152-8.
- 1997
Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease,
J Chromatogr B Biomed Sci Appl, vol. 702, no. 1-2, pp. 131-41.
Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease,
Pharm Res, vol. 14, no. 12, pp. 1804-10.
- 1996
A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease,
Mov Disord, vol. 11, no. 6, pp. 633-8. DOI
- 1995
Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories,
Mov Disord, vol. 10, no. 4, pp. 433-9. DOI


